Rothschild & Co Asset Management US’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,553
Closed -$5.03M 273
2021
Q2
$5.03M Sell
7,553
-8,993
-54% -$5.99M 0.06% 220
2021
Q1
$14.4M Sell
16,546
-4,684
-22% -$4.06M 0.18% 160
2020
Q4
$19.7M Sell
21,230
-2,792
-12% -$2.59M 0.25% 137
2020
Q3
$24.7M Sell
24,022
-2,623
-10% -$2.7M 0.44% 86
2020
Q2
$27M Buy
26,645
+21,364
+405% +$21.6M 0.4% 92
2020
Q1
$4.59M Sell
5,281
-1,147
-18% -$996K 0.07% 254
2019
Q4
$6.89M Buy
6,428
+633
+11% +$679K 0.07% 271
2019
Q3
$5.36M Sell
5,795
-68
-1% -$62.9K 0.06% 280
2019
Q2
$6.62M Buy
5,863
+352
+6% +$398K 0.07% 275
2019
Q1
$7.49M Sell
5,511
-661
-11% -$898K 0.08% 271
2018
Q4
$7.14M Buy
6,172
+348
+6% +$403K 0.09% 274
2018
Q3
$8.85M Sell
5,824
-146
-2% -$222K 0.09% 277
2018
Q2
$9.34M Buy
5,970
+54
+0.9% +$84.5K 0.1% 270
2018
Q1
$6.83M Sell
5,916
-238
-4% -$275K 0.08% 274
2017
Q4
$7.29M Sell
6,154
-778
-11% -$922K 0.08% 268
2017
Q3
$9.32M Sell
6,932
-309
-4% -$416K 0.1% 259
2017
Q2
$5.85M Sell
7,241
-199
-3% -$161K 0.07% 277
2017
Q1
$4.59M Buy
7,440
+38
+0.5% +$23.4K 0.05% 281
2016
Q4
$3.96M Buy
7,402
+2,128
+40% +$1.14M 0.05% 297
2016
Q3
$2.73M Buy
5,274
+227
+4% +$117K 0.05% 296
2016
Q2
$2.07M Buy
5,047
+444
+10% +$182K 0.04% 319
2016
Q1
$2.45M Buy
4,603
+169
+4% +$90K 0.05% 290
2015
Q4
$3.38M Buy
4,434
+1,731
+64% +$1.32M 0.06% 295
2015
Q3
$1.48M Buy
+2,703
New +$1.48M 0.03% 316